Internal Medicine, Cardiovascular Disease · Yardley, PA
NPI
1851365308
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
301 Oxford Valley Rd Ste 901
Yardley, PA, 19067
Phone (215) 321-7400
Groups this clinician bills Medicare through
Medicare paid, 2024
$923K
5,643 services
Medicare patients, 2024
949
Average age 74
Drug cost, 2024
$1.1M
8,198 prescriptions
Company payments, 2025
$6,071
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paul Grena was code 99214 (office e&m - established), 1,096 times for 518 patients. In total Paul Grena billed 5,643 services in 34 codes, and Medicare paid $923K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-07-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,096 | 518 | $90.00 | $99K |
| 93000 Electrocardiogram | Office | 1,059 | 527 | $10.30 | $11K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 979 | 246 | $2.46 | $2,407 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 891 | 433 | $12.27 | $11K |
| 93306 Echocardiography (TTE/TEE) | Office | 286 | 282 | $143.95 | $41K |
| A9555 Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 243 | 233 | $619.43 | $151K |
| 78434 Myocardial Perfusion Scan | Office | 234 | 234 | $436.78 | $102K |
| 78431 Myocardial Perfusion Scan | Office | 234 | 234 | $1,942.25 | $454K |
| 93010 Electrocardiogram | Facility | 152 | 131 | $6.46 | $982 |
| 78452 Myocardial Perfusion Scan | Office | 59 | 59 | $342.39 | $20K |
| A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 56 | 56 | $49.01 | $2,744 |
| 93015 Electrocardiogram | Office | 41 | 41 | $55.44 | $2,273 |
| 99215 Office E&M - Established | Office | 39 | 34 | $138.89 | $5,417 |
| 99232 Hospital E&M - Subsequent | Facility | 31 | 26 | $59.83 | $1,855 |
| 99233 Hospital E&M - Subsequent | Facility | 29 | 28 | $85.03 | $2,466 |
By year: 2022 $526K for 4,199 services; 2023 $445K for 3,630 services; 2024 $923K for 5,643 services.
Medicare prescription drug claims, 2024
In 2024, the drug Paul Grena prescribed most often to Medicare patients was Rosuvastatin Calcium, with 1,667 prescriptions and refills. In total Paul Grena wrote 8,198 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 1,667 | 4,653 | 470 | $28K |
| Irbesartan Generic | 539 | 1,525 | 162 | $18K |
| Amlodipine Besylate Generic | 532 | 1,396 | 149 | $4,380 |
| Metoprolol Succinate Generic | 498 | 1,414 | 147 | $9,037 |
| Ezetimibe Generic | 379 | 1,045 | 110 | $11K |
| Eliquis Apixaban | 367 | 698 | 83 | $398K |
| Carvedilol Generic | 311 | 875 | 89 | $3,790 |
| Atorvastatin Calcium Generic | 297 | 786 | 83 | $3,979 |
| Losartan Potassium Generic | 265 | 705 | 74 | $2,788 |
| Irbesartan-Hydrochlorothiazide Irbesartan/Hydrochlorothiazide | 253 | 689 | 71 | $7,359 |
| Diltiazem 24hr Er (Cd) Diltiazem Hcl | 220 | 608 | 64 | $8,674 |
| Clopidogrel Clopidogrel Bisulfate | 211 | 598 | 57 | $3,142 |
| Repatha Sureclick Evolocumab | 156 | 239 | 26 | $132K |
| Metoprolol Tartrate Generic | 148 | 418 | 47 | $1,341 |
| Hydralazine Hcl Generic | 138 | 301 | 39 | $1,623 |
Brand drugs: 982 claims; generic drugs: 7,216 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paul Grena $6,071 ($6,071 in general payments such as food, travel and fees) from 20 companies. The largest payer was Merck Sharp & Dohme LLC with $4,863.
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC MRK | 25 | $4,863 |
| Amgen Inc. AMGN | 10 | $186 |
| Pfizer Inc. PFE | 11 | $165 |
| Cleerly, Inc. | 1 | $127 |
| Novo Nordisk Inc NVO | 6 | $126 |
| Novartis Pharmaceuticals Corporation NVS | 7 | $117 |
| Lilly USA, LLC LLY | 2 | $92.51 |
| Esperion Therapeutics, Inc. ESPR | 4 | $78.21 |
| Scpharmaceuticals Inc. SCPH | 3 | $72.4 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $61.78 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.